Mark G. Foletta - 08 May 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Mark G. Foletta
Issuer symbol
DXCM
Transactions as of
08 May 2025
Net transactions value
$0
Form type
4
Filing time
12 May 2025, 16:08:00 UTC
Previous filing
06 May 2025
Next filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FOLETTA MARK G Director 6340 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Mark G. Foletta 12 May 2025 0001236389

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Gift $0 -2,973 -100% $0.000000 0 08 May 2025 Direct F1
transaction DXCM Common Stock Gift $0 +2,973 +5.3% $0.000000 59,371 08 May 2025 by Trust F1, F2
transaction DXCM Common Stock Award $0 +5,731 $0.000000 5,731 08 May 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units.
F2 Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.
F3 The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.